Advanced search
Publication Cover
Infection and Drug Resistance Volume 15, 2022 - Issue
Submit an article Journal homepage
220
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Ceftolozane/Tazobactam Activity Against Drug-Resistant Pseudomonas aeruginosa and Enterobacterales Causing Healthcare-Associated Infections in Eight Asian Countries: Report from an Antimicrobial Surveillance Program (2016–2018)

Michael Pfaller1 JMI Laboratories, North Liberty, IA, USA;2 University of Iowa College of Medicine, Iowa City, IA, USAView further author information
,
Dee Shortridge1 JMI Laboratories, North Liberty, IA, USACorrespondence[email protected]
View further author information
,
Wei-Ting Chen3 Merck & Co., Inc, Kenilworth, NJ, USAView further author information
,
Helio Sader1 JMI Laboratories, North Liberty, IA, USAView further author information
&
Mariana Castanheira1 JMI Laboratories, North Liberty, IA, USAView further author information
Pages 6739-6753 | Received 30 Aug 2022, Accepted 14 Nov 2022, Published online: 22 Nov 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.